Autogenous Vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Control: Biotechnological Advances and Veterinary Applications
Veterinary Sciences · 05.11.2026 · 13 (11) · 1196
DOI: 10.3390/vetsci13111196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 05.11.2026. Verfasst von Carlos A. García-Munguía und 12 weiteren Autor:innen. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Porcine reproductive and respiratory syndrome virus (PRRSV) remains one of the most economically significant pathogens of global swine production, and its genetic variability limits the field effectiveness of commercially licensed vaccines. Autogenous vaccines prepared from isolates recovered within a defined epidemiological unit are used at scale as a herd-specific alternative. This review distinguishes authorized autogenous products from experimental herd-specific preparations and from precision-vaccinology platforms that are neither authorized nor, given current development timelines, compatible with the autogenous use case. Following a structured search, the primary evidence base for efficacy is synthesized and found to comprise three studies from two research groups, including a single randomized controlled field trial. That evidence supports reductions in viraemia and lung pathology after homologous challenge, but not heterologous protection, and no study reports reproductive outcomes. The regulatory frameworks of the European Union, the United States and Mexico are compared, and are shown to authorize these products without requiring a demonstration of efficacy. Inactivation validation criteria, safety, breeding animals, interference with surveillance, isolate selection, where multiple variants co-circulate, and the absence of published economic evaluation are examined, together with the Latin American context, for which no field experience has been published.
Zitieren
APA
García-Munguía, C. A., García-Munguía, O., Bamidele, M. O., Flores-López, M. L., Cisneros-Guzmán, L. F., Plascencia-Espinosa, M. A., Ocaranza-Sánchez, E., Torre, R. R. R. L., Robles-López, M. R., García-Munguía, A. M., Correa-Morales, F., Ramírez-López, C., & García-Munguía, A. (2026). Autogenous Vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Control: Biotechnological Advances and Veterinary Applications. Veterinary Sciences, 13(11), 1196. https://doi.org/10.3390/vetsci13111196
Vancouver
García-Munguía CA, García-Munguía O, Bamidele MO, Flores-López ML, Cisneros-Guzmán LF, Plascencia-Espinosa MA, et al. Autogenous Vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Control: Biotechnological Advances and Veterinary Applications. Veterinary Sciences. 2026;13(11):1196. doi:10.3390/vetsci13111196
BibTeX
@article{GarcaMungua2026,
author = {García-Munguía, Carlos A. and García-Munguía, Otilio and Bamidele, Muyideen O. and Flores-López, María L. and Cisneros-Guzmán, Luis F. and Plascencia-Espinosa, Miguel A. and Ocaranza-Sánchez, Erik and Torre, Raúl R. Robles-de la and Robles-López, María R. and García-Munguía, Alberto M. and Correa-Morales, Fabian and Ramírez-López, Carolina and García-Munguía, Argelia},
title = {Autogenous Vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Control: Biotechnological Advances and Veterinary Applications},
journal = {Veterinary Sciences},
year = {2026},
volume = {13},
number = {11},
pages = {1196},
doi = {10.3390/vetsci13111196}
}
EUVIMED